1 / 37

Chapter 3

Chapter 3.  Pulmonary Function Study Assessments. Introduction. Pulmonary function studies are used to: Evaluate pulmonary causes of dyspnea Differentiate between obstructive and restrictive pulmonary disorders Assess severity of the pathophysiologic impairment

vicki
Télécharger la présentation

Chapter 3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 3  Pulmonary Function Study Assessments

  2. Introduction • Pulmonary function studies are used to: • Evaluate pulmonary causes of dyspnea • Differentiate between obstructive and restrictive pulmonary disorders • Assess severity of the pathophysiologic impairment • Follow the course of a particular disease • Evaluate the effectiveness of therapy • Assess the patient’s preoperative status

  3. Normal Lung Volumesand Capacities

  4. Table 3-1. Lung Volumes and Capacities of Normal Recumbent Subjects 20 to 30 Years of Age

  5. Table 3-2. Restrictive Lung Disorders: Lung Volume and Capacity Findings

  6. Table 3-4. Obstructive Lung Disorders: (Lung Volume and Capacity Findings)

  7. Table 3-5. Anatomic Alterations of the Lungs Associated with Obstructive Lung Disorders: (Pathology of the Tracheobronchial Tree)

  8. Figure 3-1. Visual comparison of lung volumes and capacities in obstructive and restrictive lung disorders. (From Wilkins RL, Stoller JK, Scanlan CL: Egan’s fundamentals of respiratory care, ed 9, St Louis, 2009, Elsevier.)

  9. Indirect Measurements of the Residual Volume and Capacities Containing the Residual Volume • Closed-circuit helium dilution test • Open-circuit nitrogen washout test • Body plethysmography

  10. Forced Expiratory Flow Rate and Volume Measurements

  11. Forced Vital Capacity (FVC) • The FVC is the total volume of gas that can be exhaled as forcefully and rapidly as possible after a maximal inspiration.

  12. Figure 3-2. Forced vital capacity (FVC). A is the point of maximal inspiration and the starting point of an FVC maneuver. Note the reduction in FVC in obstructive pulmonary disease.

  13. Forced Expiratory Volume (FEVT) • The maximum volume of gas that can be exhaled over a specific period is the FEVT. • This measurement is obtained from an FVC measurement. • Commonly used time periods are 0.5, 1.0, 2.0, 3.0, and 6.0 seconds • The most commonly used time is 1 second (FEV1 ).

  14. Figure 3-3. Forced expiratory volume timed (FEVT). In obstructive pulmonary disease, more time is needed to exhale a specified volume.

  15. Forced Expiratory Volume (FEVT) (Cont’d) • In the normal adult, the percentage of total volume exhaled during these time periods: • FEV0.5: 60% • FEV1: 80% • FEV2: 94% • FEV3: 97%

  16. Forced Expiratory Volume in 1 Second/ForcedVital Capacity Ratio (FEV1/FVC Ratio)(also abbreviated as FEV1%)

  17. FEV1/FVC RatioorFEV1% • The FEV1/FVC ratio compares the amount of air exhaled in 1 second with the total amount exhaled during an FVC maneuver.

  18. FVC, FEV1, and FEV1% • Clinically, the FVC, FEV1, and FEV1% are commonly used to: • Assess the severity of a patient’s pulmonary disorder and • Determine whether the patient has an obstructive or a restrictive disease

  19. FVC, FEV1, and FEV1% (Cont’d) • The primary pulmonary function study difference between an obstructive and a restrictive lung disorder are as follows: • In an obstructive disorder, the FEV1 and FEV1% are both decreased. • In a restrictive disorder, the FEV1 is decreased and FEV1% is normal or increased.

  20. Forced Expiratory Flow25%-75% • The FEF25%-75% is the average flow rate generated by the patient during the middle 50% of an FVC measurement. • FEF25%-75% is used to evaluate the status of medium-to-small airways in obstructive lung disorders.

  21. Figure 3-4. FEF25%-75%. This test measures the average rate of flow between 25% and 75% of an FVC.

  22. Forced Expiratory Flow200-1200 • The FEF200-1200 measures the average flow rate between 200 and 1200 mL of an FVC. • The FEF200-1200 provides a good assessment of the large upper airways.

  23. Forced Expiratory Flow200-1200 (Cont’d) • The FEF200-1200 measures the average flow rate between 200 and 1200 mL of an FVC. • The FEF200-1200 provides a good assessment of the large upper airways.

  24. Figure 3-5. FEF200-1200. This test measures the average rate of flow between 200 mL and 1200 mL of an FVC.

  25. Peak Expiratory Flow Rate • The PEFR is the maximum flow rate generated during an FVC maneuver.

  26. ˙ ˙ Figure 3-6. PEFR. The steepest slope of the DV/DT line is the PEFR (V).

  27. Maximum Voluntary Ventilation (MVV) • The MVV is the largest volume of gas that can be breathed voluntarily in and out of the lungs in 1 minute. • Note: The patient effort during the MVV is for only 12 to 15 seconds. The total 1 minute MVV is extrapolated from these data.

  28. Figure 3-7. Volume-time tracing for an MVV maneuver.

  29. Flow-Volume Loop • The flow-volume loop is a graphic illustration of both a forced vital capacity (FVC) maneuver and a forced inspiration volume (FIV) maneuver.

  30. Flow-Volume Loop (Cont’d) • Depending of the sophistication of equipment, several important pulmonary function study values can be obtained, including: • FVC • FEVT • FEF25%-75% • FEF200-1200 • PEFR • Peak inspiratory flow rate (PIFR) • FEF50% • Instantaneous flow at any given lung volume during forced inhalation and exhalation

  31. Figure 3-8. Flow-volume loop.

  32. Figure 3-9. Flow-volume loop demonstrating the shape change that results from an obstructive lung disorder. The curve on the right represents intrathoracic airway obstruction.

  33. Figure 3-7. Volume-time tracing for a maximum voluntary ventilation (MVV) maneuver. Note: the patient actually performs the MVV maneuver for only 12 sec, not 60 sec.

  34. Figure 3-10. Flow-volume loop demonstrating the shape change that results from a restrictive lung disorder. Note the symmetric loss of flow and volume.

  35. Table 3-8. Obstructive Lung Diseases: Forced Expiratory Flow Rate and Volume Findings

  36. Pulmonary Diffusion Capacity • The pulmonary diffusion capacity of carbon monoxide (DLCO) measures the amount of carbon monoxide (CO) that moves across the alveolar-capillary membrane.

  37. Table 3-9. Pulmonary Diffusion Capacity of Carbon Monoxide (DLCO)

More Related